معرفی
Luca Boldrini serves as a Radiation Oncologist at Fondazione Policlinico Universitario 'A. Gemelli' IRCCS in Rome, Italy, while also holding a teaching staff position at the University Campus Bio-Medico di Roma (UniCamillus). He coordinates the MRI-guided radiotherapy research program and focuses clinically on lung cancer treatment. His academic qualifications include a PhD in Oncological Sciences from Università Cattolica del Sacro Cuore (2021) and a National Scientific Qualification as Associate Professor (06/I1-MED36) in 2022.
Education:
- PhD in Oncological Sciences (2021), Università Cattolica del Sacro Cuore, Rome, Italy
Research interests encompass MRI-guided radiotherapy, radiomics, and imaging applications in personalized medicine. He actively explores innovative technologies to enhance cancer care, particularly in radiotherapy and diagnostic imaging integration. His work bridges clinical practice (lung cancer treatment) with advanced research in precision oncology.
Scientific Awards: None explicitly listed in the provided text.
Advising and Grants: No formal advisees or grants are mentioned. However, he serves as clinical director of the 'In-room MR-Guided Radiotherapy' course at the European Society for Radiotherapy and Oncology (ESTRO) and contributes to academic leadership through his role in the young board of AIRO (Associazione Italiana di Radioterapia ed Oncologia clinica).
Labs and Teams: Coordinates the MRI-guided radiotherapy research program at Fondazione Policlinico Universitario 'A. Gemelli' IRCCS and collaborates with ESTRO on educational initiatives in radiotherapy. His research is embedded within interdisciplinary teams focused on oncological imaging and technology implementation.
